Alfacell denied skirting FDA regulations.
In a letter to the Food and Drug Administration, the Bloomfield, N.J.-based company said it did not try to circumvent FDA regulations in shipping its test substance Pannon (an anti-tumor agent) to the Dominican Republic. Alfacell told the FDA that it will apply for permission to export Pannon for the purpose of scientific investigation.
Start your day right
Sign up for Essential California for news, features and recommendations from the L.A. Times and beyond in your inbox six days a week.
You may occasionally receive promotional content from the Los Angeles Times.
